TL;DR
- 1.'10 units' is not a dose. Off an 80 mg vial it delivers 4 mg, 2.67 mg or 2 mg depending only on how much water the chart told you to add.
- 2.GLOW ships as 35 mg, 42 mg and 70 mg vials under the same name, with different ratios. Two people running 'the GLOW protocol' can be on doses that differ nearly twofold.
- 3.GHK-Cu is 15.8% copper by weight. An 80 mg KLOW vial holds about 7.9 mg of elemental copper, and injecting bypasses the gut, which is where your body actually regulates copper.
- 4.TB-500 is a 7-amino-acid fragment. Every human trial used the full 43-amino-acid protein, and tested dry eye and leg ulcers rather than tendons.
- 5.Searching 'sermorelin' returns 24 papers and zero trials. Searching its old name, GRF(1-29), returns 579 papers and 39 randomised trials. Same compound.
You found a dosing chart. It says 10 units. Another site says 10 units too, but it also told you to mix the vial with a different amount of water, which means the two charts are describing doses that differ by twofold.
Neither chart mentions this. Here are seven reasons peptide dosing numbers contradict each other, and what to check before you trust any of them.
1. "Units" measure liquid, not drug
An insulin syringe is marked in units, and a unit is a volume: 1 unit is 0.01 mL. It tells you nothing about how much compound is in that volume. That depends entirely on how concentrated you made the vial.
Take one 80 mg KLOW vial and follow three different charts:
| Water added | Concentration | What "10 units" delivers |
|---|---|---|
| 2 mL | 40 mg/mL | 4.0 mg |
| 3 mL | 26.7 mg/mL | 2.67 mg |
| 4 mL | 20 mg/mL | 2.0 mg |
Same vial. Same syringe marking. Twice the dose at one end versus the other. If a chart gives you a unit count without stating the reconstitution volume in the same breath, it has not actually told you a dose.
2. The same product name covers different products
GLOW is sold as a 70 mg vial (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500). It is also sold as a 42 mg vial with a different split, and a 35 mg vial. All three are "GLOW".
So the ratio moves, not just the strength. Ten units off a 70 mg vial and ten units off a 42 mg vial give you different amounts of GHK-Cu and different amounts of BPC-157 relative to it. A protocol copied from someone running a different vial is not the same protocol.
Check the milligram breakdown printed on your own vial or its certificate of analysis. Not the blend name.
3. Blend doses and component doses get mixed up
A page will headline "250 to 750 mcg" and then, further down, show a table where those numbers are per component. In a four-part blend, those are wildly different instructions.
KLOW is roughly 5 parts GHK-Cu to 1 part each of the other three. So a draw big enough to give you 500 mcg of BPC-157 also gives you 2.5 mg of GHK-Cu. When a chart quotes a single number, work out which one it means before you act on it.
4. Fixed-ratio blends cannot be titrated
This is the part almost nobody mentions. In a pre-mixed vial you cannot adjust one component. The ratio is set at manufacture.
If you want more of the repair peptides, you take proportionally more copper peptide whether you want it or not. Any dose that lands one component where you want it puts the others wherever the ratio says. Buying components separately costs more effort and two vials, and it is the only way to move them independently.
5. Copper is a dose, and injecting skips the checkpoint
GHK-Cu is about 15.8% copper by weight. An 80 mg KLOW vial therefore holds roughly 7.9 mg of elemental copper.
Per injection that is a small amount, below what you would get from a good day's food. The part worth knowing is different: the familiar daily copper limits are written for eating, where your gut decides how much to absorb and refuses the rest. Injecting goes around that entirely, and nobody has set a limit for copper delivered that way. It is a missing checkpoint rather than an overdose, and it is a genuine reason to care which vial size you bought.
6. The molecule in the vial may not be the molecule in the study
TB-500 is a seven-amino-acid fragment. The human trials people cite for it used thymosin beta-4, the full 43-amino-acid protein, and they tested severe dry eye and venous leg ulcers. Not tendons.
CJC-1295 has the same problem in a different shape. It exists with DAC and without. With DAC it keeps growth hormone elevated for days; without it, you get a pulse lasting minutes. The single human trial used the DAC version. The blends sold with ipamorelin almost always contain the other one. A dose from one does not transfer to the other.
7. A compound can look unstudied because of its name
Search PubMed for "sermorelin" and you get 24 papers and no trials, which looks damning. Search its older chemical name, GRF(1-29), and you get 579 papers including 39 randomised trials.
Same compound. The research was published before and around the brand name, so the brand name misses it. This cuts both ways: ipamorelin genuinely has only two human trials, and neither one looked at muscle, fat or sleep. One was about restarting the bowel after abdominal surgery.
The 30-second check
Before you use any chart, ask it four questions:
- Does it state the reconstitution volume next to the unit count? If not, the unit count is meaningless.
- Does the milligram breakdown match the vial in your hand? Blend names are not specifications.
- Is the number per blend or per component? In a 5:1:1:1 blend this changes everything.
- Does it link the study, or just name it? A citation you cannot click is a citation nobody checked.
That last one matters more than it sounds. When we checked the studies behind our own pages, five citations pointed at completely unrelated papers while still returning a working link: a copper peptide review that resolved to a paper on rice bran, a gut peptide study that resolved to heart transplantation. Every one of them looked fine until someone opened it.
None of this tells you what dose to take, and that is deliberate: for most of these blends there is no established dose to give you, because no trial has tested them. What it does tell you is when a number you are reading was never a number at all.
Your DNA shapes how you respond to the peptides discussed above.
A personalized report scores 39 peptides against your unique genetic profile — including the ones covered in this article.
Frequently asked questions
Why do peptide dosing charts disagree so much?
Mostly because 'units' measure volume, not drug. A unit is 0.01 mL on an insulin syringe, so the amount of compound it contains depends entirely on how much water was added to the vial. An 80 mg vial mixed with 2 mL delivers 4 mg per 10 units; the same vial mixed with 4 mL delivers 2 mg. Charts that quote units without stating the reconstitution volume are not describing a dose.
Is 10 units the same on every vial?
No. Ten units is always 0.1 mL of liquid, but how much peptide is in that 0.1 mL depends on the vial size and the water you added. It also depends on the blend: GLOW is sold as 35 mg, 42 mg and 70 mg vials with different ratios under the same name, so ten units can differ nearly twofold between two vials both labelled GLOW.
How much copper is in a KLOW vial?
GHK-Cu is roughly 15.8% copper by weight, so the 50 mg of GHK-Cu in a standard 80 mg KLOW vial contains about 7.9 mg of elemental copper. Spread across a cycle, each injection carries a small amount. The reason it is worth knowing is that injecting bypasses the intestine, which is where your body normally regulates how much copper it absorbs, and no limit has been established for copper given that way.
Can I adjust one peptide in a pre-mixed blend?
No. The ratio is fixed at manufacture, so any draw that puts one component where you want it puts the others wherever the ratio dictates. In KLOW that is roughly 5 parts GHK-Cu to 1 part each of KPV, BPC-157 and TB-500. Buying components separately is the only way to dose them independently, at the cost of more vials and more mixing.
Is TB-500 the same as thymosin beta-4?
Not quite, and the difference matters when reading studies. TB-500 is a seven-amino-acid fragment; thymosin beta-4 is the full 43-amino-acid protein. The human trials commonly cited for TB-500 used the full protein and tested severe dry eye and venous leg ulcers, not the tendon and muscle injuries the fragment is usually sold for.
This article is for informational and educational purposes only. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any peptide protocol. Individual results vary.